|
Sub-types of cardiomyopathies
|
Pattern of enhancement
|
|---|
|
Sub-endocardial
|
Mid-wall
|
Sub-epicardial
|
Transmural
|
|---|
|
Primary dilated
|
–
|
1
| | |
|
Secondary dilated post myocarditis
|
–
|
2*
|
2*
|
4
|
|
Secondary dilated toxins, drugs**
|
–
|
–
|
–
|
–
|
|
Hypertrophic
|
–
|
4
| | |
|
Non-compaction
|
–
|
–
|
–
|
–
|
|
ARVD
|
–
|
1***
|
–
|
–
|
|
Restrictive
|
–
|
–
|
–
|
–
|
|
Infiltrative thalassemia
|
–
|
–
|
–
|
–
|
|
Infiltrative others
|
–
|
1
|
–
|
–
|
|
Ischemic
|
2
|
–
|
–
|
–
|
- *There is overlapping in the total number as two cases show both the mid-wall and epicardial enhancement
- **No LGE; however, there is increase first pass perfusion
- ***The enhancement involving RVOT
